Search

Author/Creator Thomas, Paul G.

1. Back Cover: Discovery of a Highly Selective PLD2 Inhibitor (ML395): A New Probe with Improved Physiochemical Properties and Broad‐Spectrum Antiviral Activity against Influenza Strains (ChemMedChem 12/2014). Issue 12 (December 2014)

Authors:
O'Reilly, Matthew C.; Oguin, Thomas H.; Scott, Sarah A.; Thomas, Paul G.; Locuson, Charles W.; Morrison, Ryan D.; Daniels, J. Scott; Brown, H. Alex; Lindsley, Craig W.
Journal:
ChemMedChem
Issue:
Volume 9:Issue 12(2014:Dec.)
Page Start:
2820
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Discovery of a Highly Selective PLD2 Inhibitor (ML395): A New Probe with Improved Physiochemical Properties and Broad‐Spectrum Antiviral Activity against Influenza Strains. Issue 12 (10th September 2014)

Authors:
O'Reilly, Matthew C.; Oguin, Thomas H.; Scott, Sarah A.; Thomas, Paul G.; Locuson, Charles W.; Morrison, Ryan D.; Daniels, J. Scott; Brown, H. Alex; Lindsley, Craig W.
Journal:
ChemMedChem
Issue:
Volume 9:Issue 12(2014:Dec.)
Page Start:
2633
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. PKC agonism restricts innate immune suppression, promotes antigen cross-presentation and synergizes with agonistic CD40 antibody therapy to activate CD8+ T cells in breast cancer. (10th April 2022)

Authors:
Chaib, Mehdi; Sipe, Laura M.; Yarbro, Johnathan R.; Bohm, Margaret S.; Counts, Brittany R.; Tanveer, Ubaid; Pingili, Ajeeth K.; Daria, Deidre; Marion, Tony N.; Carson, James A.; Thomas, Paul G.; Makowski, Liza
Journal:
Cancer letters
Issue:
Volume 531(2022)
Page Start:
98
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗